Latest News

Triple therapy revs up immune system against common brain tumor

A triple therapy for glioblastoma, including two types of immunotherapy and targeted radiation, has significantly prolonged the survival of mice with these brain cancers, according to a new report. Mice with implanted, mouse-derived glioblastoma cells lived an average of 67 days after the triple therapy, compared with mice that lasted 24 days when they received only the two immunotherapies.
View full story

Post your comment.


  • Math story time at home bolsters achievement in school

  • Seeing in a new light

  • Smoking, heavy alcohol use are associated with epigenetic signs of aging

  • Opposites don't attract when learning how to use a prosthesis

  • Scientists build a digital piece of a rat's brain

  • Machines have nothing on mom when it comes to listening

  • New clues about how humans become tool users

  • Researchers learn how to grow old brain cells

  • Frequent school moves hurt low-income childrens' math scores

  • More 'global' individuals contribute less